Monday, April 22, 2024

Novogene Asia Pacific Middle East and Africa adopts Olink® Explore HT technology to accelerate multi-omics research with next generation proteomics

Novogene Asia Pacific Middle East and Africa adopts Olink® Explore HT technology to accelerate multi-omics research with next generation proteomics


UPPSALA, Sweden, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) ("Olink") (NASDAQ:OLK) today announced that Novogene Asia Pacific Middle East and Africa (AMEA) has adopted the Olink Explore HT platform to deliver advanced next-generation proteomics technology to the scientific community in the region.

Novogene is a leading provider of genomic services and solutions offering extensive next generation sequencing (NGS) capacity and bioinformatics expertise. The addition of Olink Explore HT significantly increases Novogene AMEA's capabilities and quality of multi-omics research services offerings. Olink Explore HT represents the state of the art in next generation proteomics, allowing scientists to accurately measure over 5,400 proteins using only 2µl of sample. By combining Olink PEA technology with an NGS readout of relative protein concentrations, each thoroughly validated assay produces unmatched specificity and sensitivity.

"The addition of the Olink Explore platform to the Novogene portfolio marks our commitment to delivering the latest multi-omics solutions to the scientific community in Asia Pacific, Middle East and Africa region. By seamlessly integrating Olink's proteomics technology with our existing capabilities in genomics, transcriptomics, metagenomics and epigenomics, we hope to help researchers unlock a new layer of actionable data. This initiative will elevate our ability to provide extraordinary insights into disease biology, paving the way for more impactful discoveries." said Justin Lee, Vice President of Novogene AMEA.

"We are immensely pleased to see Olink® Explore ...

Full story available on Benzinga.com